Megasoft Ltd
Incorporated in 1999, Megasoft Ltd is
in the business of providing Telecom
services[1]
- Market Cap ₹ 523 Cr.
- Current Price ₹ 70.8
- High / Low ₹ 107 / 28.6
- Stock P/E
- Book Value ₹ 24.5
- Dividend Yield 0.00 %
- ROCE 7.58 %
- ROE -6.82 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 2.89 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -0.60% over last 3 years.
- Earnings include an other income of Rs.37.4 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
114 | 103 | 98 | 63 | 67 | 66 | 62 | 57 | 59 | 52 | 2 | 0 | |
93 | 80 | 73 | 47 | 62 | 57 | 60 | 51 | 55 | 71 | 20 | 9 | |
Operating Profit | 21 | 23 | 25 | 16 | 6 | 10 | 2 | 5 | 4 | -18 | -18 | -9 |
OPM % | 19% | 22% | 25% | 25% | 8% | 14% | 3% | 9% | 7% | -35% | -898% | |
3 | 3 | 1 | 1 | 8 | 1 | 9 | 6 | 7 | 30 | 43 | 37 | |
Interest | 11 | 11 | 12 | 8 | 6 | 5 | 6 | 7 | 5 | 3 | 11 | 17 |
Depreciation | 12 | 12 | 14 | 7 | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 3 |
Profit before tax | 2 | 3 | 0 | 2 | 2 | 1 | 1 | 1 | 2 | 5 | 11 | 8 |
Tax % | 29% | 8% | -208% | 26% | -24% | -55% | 53% | -6% | 0% | 12% | 0% | 8% |
1 | 3 | 1 | 1 | 3 | 2 | 0 | 1 | 2 | 5 | 9 | -13 | |
EPS in Rs | 0.16 | 0.36 | 0.10 | 0.18 | 0.37 | 0.23 | 0.04 | 0.10 | 0.25 | 0.63 | 1.20 | -1.73 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -100% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -262% |
Stock Price CAGR | |
---|---|
10 Years: | 24% |
5 Years: | 61% |
3 Years: | 83% |
1 Year: | 140% |
Return on Equity | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | -1% |
Last Year: | -7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 44 | 44 | 44 | 44 | 44 | 44 | 44 | 44 | 44 | 74 | 74 | 74 |
Reserves | 170 | 166 | 126 | 84 | 87 | 91 | 93 | 96 | 97 | 111 | 120 | 107 |
108 | 92 | 94 | 98 | 46 | 47 | 41 | 40 | 34 | 29 | 146 | 147 | |
39 | 49 | 49 | 56 | 96 | 114 | 144 | 151 | 141 | 73 | 38 | 38 | |
Total Liabilities | 360 | 351 | 312 | 282 | 273 | 297 | 322 | 331 | 317 | 286 | 377 | 366 |
209 | 205 | 193 | 194 | 187 | 141 | 208 | 243 | 248 | 204 | 179 | 187 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 58 | 31 | 0 | 0 | 0 | 0 | 0 |
Investments | 12 | 12 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 133 | 112 |
139 | 134 | 108 | 88 | 86 | 98 | 83 | 89 | 69 | 82 | 65 | 66 | |
Total Assets | 360 | 351 | 312 | 282 | 273 | 297 | 322 | 331 | 317 | 286 | 377 | 366 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-1 | 28 | -14 | 16 | 45 | 16 | 51 | 17 | 20 | 16 | 13 | 42 | |
-6 | -7 | -1 | -12 | 9 | -12 | -38 | -6 | -3 | -10 | -131 | -8 | |
18 | -30 | 9 | -3 | -58 | -4 | -11 | -8 | -16 | 22 | 85 | -19 | |
Net Cash Flow | 11 | -9 | -6 | 1 | -4 | 0 | 2 | 3 | 1 | 28 | -33 | 15 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 208 | 235 | 326 | 377 | 343 | 411 | 345 | 382 | 191 | 158 | 0 | |
Inventory Days | ||||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 208 | 235 | 326 | 377 | 343 | 411 | 345 | 382 | 191 | 158 | 0 | |
Working Capital Days | 211 | 203 | 209 | 168 | -9 | -51 | -314 | -356 | -394 | -57 | 6,396 | |
ROCE % | 4% | 5% | 4% | 4% | 0% | 3% | 4% | 4% | 4% | 2% | 8% |
Documents
Announcements
- Closure of Trading Window 26 Jun
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
21 May - Compliance Under Regulation 24 (A) of SEBI (LODR) Regulations, 2015- Secretarial Compliance Report
- Board Meeting Outcome for The Board At Its Meeting Held On 15.05.2024 Considered And Approved Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended 31.03.2024 15 May
- Audited Financial Results-Standalone And Consolidated-Quarter And Year Ended 31.03.2024 15 May
- Board Meeting Intimation for Prior Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations, 2015 7 May
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1]
MSL is focused on Pharma, Aerospace and Defense Electronics areas, is in the process of acquiring a few companies, and intend to provide centralized corporate, technology, finance, leadership /management support services to such subsidiaries /associate companies